Katelyn N Robillard
YOU?
Author Swipe
View article: Altering gene expression using antisense oligonucleotide therapy for hearing loss
Altering gene expression using antisense oligonucleotide therapy for hearing loss Open
Hearing loss affects more than 430 million people, worldwide, and is the third most common chronic physical condition in the United States and Europe (GBD Hearing Loss Collaborators, 2021; NIOSH, 2021; WHO, 2021). The loss of hearing signi…